Triaging the 911 call to a home visit instead of an ambulance-to-ED default — treat-in-place, alternative destination, and mobile integrated healthcare
Community paramedicine (CP), also called Mobile Integrated Healthcare (MIH), reroutes a subset of 911 calls away from the default reflex of "transport everyone to the nearest ED." The first decision point is at the dispatch center itself, using secondary triage protocols layered on top of standard priority dispatch to flag calls that are medically low-risk but socially or logistically complex.
Dispatch-level screening for CP-appropriate calls layers strict exclusion criteria on top of the standard Medical Priority Dispatch System (MPDS):
Automatic exclusions (always full ALS response): • Chest pain, syncope, or cardiac symptoms in a patient >35 • Any report of altered mental status, seizure, or stroke symptoms • Respiratory distress, cyanosis, or SpO2 <92% reported by caller • Trauma, active bleeding, or mechanism of injury • Obstetric emergency or pediatric patient <2 years
CP-eligible categories: • Known chronic-disease registry match (CHF, COPD, ESRD on dialysis) calling for a "routine" exacerbation • Frequent 911 utilizer (≥4 calls / 30 days) without a new acute complaint • Post-hospital-discharge patient within a 7–30 day high-risk window (identified via hospital partnership data feed) • Non-emergent requests: medication refill confusion, wound check, lift-assist without injury, behavioral health check-in
Dispatchers use a scripted secondary questionnaire (analogous to ProQA add-on modules) to confirm eligibility before diverting the call from standard ALS/BLS response to the CP unit queue. If any red-flag answer appears, the call is immediately escalated back to standard dispatch — the CP pathway is opt-in only after ruling out danger, never a substitute for triage of an ambiguous emergency.
Community paramedics operate under expanded scope-of-practice protocols authorized by state EMS offices and a supervising medical director, specifically designed for non-emergent, longitudinal, and preventive care rather than acute stabilization and transport.
A CP visit is structured less like an emergency response and more like an urgent home-health visit:
Vitals trending: comparison against the patient’s own baseline (pulled from a shared EHR or home monitoring device), not just population norms — a CHF patient’s "abnormal" weight gain of 2kg over 3 days is more actionable than a single blood pressure reading.
Medication reconciliation: physically counting pill bottles, checking for duplicate therapy, missed doses, or drug interactions — estimated to be a contributing factor in 20–30% of preventable readmissions.
Point-of-care diagnostics: portable BNP or NT-proBNP for CHF decompensation, capillary glucose and ketones, INR for warfarin patients, i-STAT panels for electrolytes/lactate in select programs.
Home safety and social assessment: fall hazards, functional status (can the patient get to the bathroom, prepare food), caregiver presence, food/medication security — factors that predict readmission risk as strongly as the medical condition itself.
Structured decision support: standing orders and checklists (not free-form clinical judgment alone) define which findings mandate immediate transport versus which support telehealth-directed treat-in-place.
The single most important safety mechanism in community paramedicine is that the decision NOT to transport is never made by the paramedic alone. A supervising physician (often an emergency physician, sometimes the patient’s own PCP) reviews the case live via video/data telehealth before any alternative disposition is finalized.
The consulting physician receives, in real time: live vitals feed, POC lab values, a video view of the patient and home environment, and the CP’s structured SBAR (Situation-Background-Assessment-Recommendation) summary.
The physician can: 1. Approve treat-in-place with specific standing orders (e.g., "administer 40mg IV furosemide, recheck vitals in 30 min, schedule PCP follow-up within 48h") 2. Direct an alternative destination (urgent care, psychiatric crisis center, sobering facility) with a warm handoff call 3. Override the CP’s initial impression and mandate ED transport if anything doesn’t fit the expected pattern
Medical-legal framework: the physician of record, not the paramedic, bears final decision-making authority and documents the encounter as a billable telehealth visit (in the US, increasingly reimbursable under CMS’s ET3 — Emergency Triage, Treat, and Transport — payment model, which explicitly pays for treat-in-place and alternative-destination care rather than only transport-based reimbursement, addressing a major historical financial disincentive against exactly this kind of care.
The disposition decision translates the assessment and telehealth consult into one of three concrete pathways, each with its own protocol and documentation trail: treat-in-place, alternative destination, or (when anything is uncertain) standard ED transport.
Treat-in-place interventions are narrow and protocolized, not open-ended clinical improvisation:
CHF exacerbation: IV or oral diuretic per weight-based order, repeat vitals and pulse oximetry at 30-60 min, low-sodium diet reinforcement, PCP follow-up scheduled before the CP leaves.
Wound care / cellulitis: wound cleaning, dressing change, oral antibiotic initiation if criteria met, photo documentation for remote wound-care specialist review.
Behavioral health: de-escalation, safety planning, direct warm-handoff transport (not ambulance) to a crisis stabilization unit rather than an ED that often lacks psychiatric beds.
Alternative destination network: many programs formally contract with urgent care clinics, sobering centers, and crisis units to accept direct CP referrals — bypassing ED registration entirely, which both reduces cost and gets the patient to more appropriate, faster care.
CMS’s ET3 model (2021) was a turning point: for the first time, Medicare would reimburse an ambulance agency for treating a patient at home or transporting to an alternative destination, not only for transport to an ED. Removing this perverse financial incentive was necessary for CP programs to scale nationally.
A treat-in-place decision is not the end of the encounter — mature CP programs mandate structured follow-up and feed every case into a registry that tracks whether the decision held up, creating a continuous quality-improvement loop rare in traditional EMS.
Every CP encounter — whether treated in place, redirected, or ultimately transported — is logged in a program registry that tracks: index disposition, 24-48h follow-up outcome, any subsequent 911 call or ED visit within 7 and 30 days, and readmission if the patient had been recently hospitalized.
Safety monitoring specifically watches for the failure mode that critics worry about most: patients sent home who deteriorate. Published program data (Fort Worth MedStar, Mesa AZ, Regional EMS Authority programs, among the longest-running in the US) generally show escalation-after-treat-in-place rates in the single digits, comparable to or better than discharge-from-ED "failure to improve" rates.
Limitations and open questions: most published outcome data comes from single-program observational studies rather than randomized trials; programs vary widely in scope, medical direction rigor, and population served, making cross-program comparison difficult; and the strongest evidence exists for CHF/COPD chronic-disease cohorts, with thinner evidence for behavioral health and general low-acuity call diversion. The field is actively building a stronger evidence base as ET3 and similar payment reforms enable broader rollout and data sharing.